Inhibition of Influenza H7 Hemagglutinin-Mediated Entry

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Antanasijevic, Aleksandar ^a   Cheng, Han ^a   Wardrop, Duncan J ^a   Rong, Lijun ^a   Caffrey, Michael ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; TERT BUTYLHYDROQUINONE; 2-TERT-BUTYLHYDROQUINONE; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; HYDROQUINONE DERIVATIVE; INFLUENZA VIRUS HEMAGGLUTININ;

ANTIVIRAL ACTIVITY; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG STRUCTURE; HEMAGGLUTINATION INHIBITION; IC 50; INFLUENZA VIRUS A; INFLUENZA VIRUS A H7N9; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH; PROTEIN DEGRADATION; PROTEIN STABILITY; VIRUS ENTRY; AMINO ACID SEQUENCE; CHINA; DISEASE OUTBREAKS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; IC50; INFLUENZA, HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHINA; DISEASE OUTBREAKS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; HYDROQUINONES; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; INHIBITORY CONCENTRATION 50; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SEQUENCE ANALYSIS, DNA; VIRUS INTERNALIZATION;

EID: 84886013227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076363     Document Type: Article

References (42)

1. Gamblin SJ, Skehel JJ, (2010) Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285: 28403-28409.
2. Johnson NP, Mueller J, (2002) Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76: 105-115.
3. Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, et al. (2009) Detecting influenza epidemics using search engine query data. Nature 457: 1012-1014.
4. Chen Y, Liang W, Yang S, Wu N, Gao H, et al. (2013) Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 6736: 60903-6904.
5. Gao R, Cao B, Hu Y, Feng Z, Wang D, et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368: 1888-1897.
6. Lu SH, Xi XH, Zheng YF, Cao Y, Liu XN, et al. (2013) Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9). Biosci Trends 7: 109-112.
7. Lagoja IM, De Clercq E, (2008) Anti-influenza virus agents: synthesis and mode of action. Med Res Rev 28: 1-38.
8. van der Vries E, Stelma FF, Boucher CA, (2010) Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med 363: 1381-1382.
9. Lamb RA, (2013) Deadly H7N9 influenza virus: a pandemic in the making or a warning lesson? Am J Respir Crit Care Med 188: 1-2.
10. Hu Y, Lu S, Song Z, Wang W, Hao P, et al. (2013) Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381: 2273-2279.
11. Skehel JJ, Wiley DC, (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
12. Harrison SC, (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690-698.
13. Caffrey M, (2011) HIV envelope: Challenges and opportunities for the discovery of entry inhibitors. Trends Microbiol 19: 191-197.
14. Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, et al. (1991) Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182: 475-485.
15. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y, (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56: 152-179.
16. Ha Y, Stevens DJ, Skehel JJ, Wiley DC, (2002) H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J 21: 865-875.
17. Hoffman LR, Kuntz ID, White JM, (1997) Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J Virol 71: 8808-8820.
18. Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, et al. (1998) Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid. Virology 248: 264-274.
19. Cianci C, Yu KL, Dischino DD, Harte W, Deshpande M, et al. (1999) pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion. J Virol 73: 1785-1794.
20. Oka M, Ishiwata Y, Iwata N, Honda N, Kakigami T, (2001) Synthesis and anti-influenza virus activity of tricyclic compounds with a unique amine moiety. Chem Pharm Bull (Tokyo) 49: 379-383.
21. Deshpande MS, Wei J, Luo G, Cianci C, Danetz S, et al. (2001) An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology. Bioorg Med Chem Lett 11: 2393-2396.
22. Yu KL, Torri AF, Luo G, Cianci C, Grant-Young K, et al. (2002) Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamine. Bioorg Med Chem Lett 12: 3379-3382.
23. Russell RJ, Kerry PS, Stevens DJ, Steinhauer DA, Martin SR, et al. (2008) Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A 105: 17736-17741.
24. Han T, Marasco WA, (2011) Structural basis of influenza virus neutralization. Ann NY Acad Sci 1217: 178-190.
25. Fleishman SJ, Whitehead TA, Ekiert DC, Dreyfus C, Corn JE, et al. (2011) Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332: 816-821.
26. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333: 843-850.
27. Dreyfus C, Ekiert DC, Wilson IA, (2013) Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 hemagglutinin. J Virol 87: 7149-7154.
28. Bodian DL, Yamasaki RB, Buswell RL, Stearns JF, White JM, et al. (1993) Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32: 2967-2978.
29. van Esch GJ, (1986) Toxicology of tert-butylhydroquinone (TBHQ). Food Chem Toxicol 24: 1063-1065.
30. Gharavi N, Haggarty S, El-Kadi AO, (2007) Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites. Curr Drug Metab 8: 1-7.
31. Wang J, Sen J, Rong L, Caffrey M, (2008) Role of the HIV gp120 conserved domain 1 in processing and viral entry. J Biol Chem 283: 32644-32649.
32. Guo Y, Tisoncik J, McReynolds S, Lou G, Martinez O, et al. (2009) Identification of a small region of SARS-CoV S protein critical for viral entry. J Mol Biol 394: 600-605.
33. Yermolina M, Wang J, Caffrey M, Rong L, Wardrop D, (2011) Discovery, synthesis and biological evaluation of a novel group of selective inhibitors of filoviral entry. J Med Chem 54: 765-781.
34. Wang M, Tscherne D, McCullough C, Caffrey M, García-Sastre A, et al. (2012) Y161 is a critical residue of HA for receptor recognition. J Virol 86: 4455-4462.
35. Dalvit C, Fogliatto G, Stewart A, Veronesi M, Stockman B, (2001) WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J Biomol NMR 21: 349-359.
36. Ramirez B, Antanasijevic A, Caffrey M (2013) Ligand screening using NMR. Meth Molecul Biol, In press.
37. Meyer B, Peters T, (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed Engl 42: 864-890.
38. McCullough C, Wang M, Rong L, Caffrey M, (2012) NMR characterization of influenza hemagglutinin receptor interactions PLoS ONE. 7: e33958.
39. Delaglio F, Grzesiek S, Vuister W, Zhu G, Pfeifer J, et al. (1995) NMRPipe: A Multidimensional Spectral Processing System Based on UNIX pipes. J Biomolec NMR. 6: 277-293.
40. Ueda M, Maeda A, Nakagawa N, Kase T, Kubota R, et al. (1998) Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses. J Clin Microbiol 36: 340-344.
41. Ilyushina NA, Govorkova EA, Russell CJ, Hoffmann E, Webster RG, (2007) Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 88: 1266-1274.
42. Zhu L, Li Y, Li S, Li H, Qiu Z, et al. (2011) Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin. PLoS One 6: e29120.